Satya Surbhi

University of Tennessee Health Science Center

MedicineHealth Professions

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Safety of SGLT2 inhibitors, DPP-4 inhibitors, and GLP-1 receptor agonists in US veterans with and without chronic kidney disease: a population-based study”.

Safety of SGLT2 inhibitors, DPP-4 inhibitors, and GLP-1 receptor agonists in US veterans with and without chronic kidney disease: a population-based study

The Lancet Regional Health - Americas(2024)10.1016/j.lana.2024.100814

N/A

0.483DataRank · unranked

7 citations

Csaba P. Kövesdy, Amy S. You, Keiichi Sumida, Yamini Mallisetty, Satya Surbhi +6 more

Feasibility of a Brief Intervention to Increase Rapid Primary Care Follow-Up Among African American Patients With Uncontrolled Diabetes

Cureus(2022)10.7759/cureus.22756

N/A

0DataRank · unranked

1 citations

Elizabeth A. Tolley, Satya Surbhi, James E. Bailey, Emily M Mylhousen